Lakeland Fire + Safety will hold its fiscal second quarter 2027 earnings call on September 9, 2026, at 4:30 p.m. ET, revealing financial performance.
Browsing Category
General
97 posts
Ovintiv Announces Permian And Montney Inventory Additions
Ovintiv announces significant increases in its Permian and Montney resource inventories, boosting its upstream development prospects.
As National Wellness Month Comes To A Close, Periodontal Specialist Reminds Patients That Wellness Includes Oral Health
As National Wellness Month concludes, a periodontal specialist highlights the importance of oral health for overall wellness and encourages ongoing dental care.
JATT III Acquisition Corp Announces Pricing Of $60,000,000 Initial Public Offering
JATT III Acquisition Corp has announced the pricing of its $60 million initial public offering, marking a key step in its market entry.
Walden Media Group Named As Approved Agency Partner For WellBiz Brands
Walden Media Group has been officially designated as an Approved Agency Partner for WellBiz Brands, marking a strategic partnership in the health and wellness franchise sector.
2026-08-24 – Data Portal – Important Monetary Policy Data, 24 August 2026
Switzerland’s National Bank publishes crucial monetary policy data on August 24, 2026, providing insights into interest rates, inflation targets, and economic outlooks.
SBA, Department Of Energy Partner To Advance President Trump’s American Energy Dominance Agenda
The SBA and DOE announce a partnership to support President Trump’s American energy dominance agenda through new initiatives and funding programs.
Simply Good Foods Company (SMPL) Shareholders Who Lost Money Have Opportunity To Lead Securities Fraud Lawsuit
Shareholders who lost money in Simply Good Foods may have the opportunity to join a securities fraud lawsuit, according to recent reports.
Will It Rain In New Orleans On Aug 23, 2026?
A market predicts a 92% chance of rain in New Orleans on August 23, 2026, based on recent trades. Forecasts remain uncertain due to long-term nature.
Anbogen Therapeutics And The University Of Tokyo Enter Collaborative Research Agreement To Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
Anbogen Therapeutics and The University of Tokyo have announced a collaborative research agreement to evaluate ABT-301 across multiple tumor types, aiming to accelerate clinical development.